Article

jdsupra.com on 2016-11-15 16:36

New Developments in AbbVie’s BPCIA Suit Targeting Amgen’s Humira® Biosimilar

On August 4, 2016, AbbVie filed a complaint against Amgen alleging that Amgen’s Humira® biosimilar Amjevita® infringes ten AbbVie patents. Humira® ...

Related news

PEuropeans recommend approval of Amgen’s biosimilar of AbbVie’s Humira pacbiztimes.com
United States
FDA: Amgen’s Biosimilar “Highly Similar” to Abbvie’s Humira jdsupra.com
PFDA approves Amgen biosimilar of AbbVie’s Humira pacbiztimes.com
Ventura
PAmgen’s Humira biosimilar delayed, Enbrel approved pacbiztimes.com
FDA Approves Amgen’s Biosimilar Version of Humira wsj.com
Amgen’s Humira Biosimilar Becomes the Fourth FDA Approved Biosimilar jdsupra.com
United States
BREAKING NEWS: FDA Expected to Approve Amgen’s Humira Biosimilar Today jdsupra.com
AbbVie’s Enforcement of its ‘Patent Thicket’ For Humira Under the BPCIA Does Not Provide Cognizable Basis for an Antitrust Violation jdsupra.com
United States , Sherman , Europe
AbbVie’s Humira (adalimumab) Shatters Sales Forecasts jdsupra.com
EC Approves Amgen’s Biosimilar Adalimumab jdsupra.com
United States
PFDA approves biosimilar competitor to Amgen’s Enbrel pacbiztimes.com
Humira Biosimilar Approved As Litigation Gets Going jdsupra.com
Delaware
PAmgen settles with AbbVie over Humira biosimilar pacbiztimes.com
United States , Europe , Thousand Oaks , Ventura
DBoehringer Ingelheim settles litigation over Humira biosimilar dailyvoiceplus.com
Fairfield , West Chester , Ridgefield , Germany
FDA Approves Novartis’s Biosimilar to Amgen’s Enbrel wsj.com
PFDA approves biosimilar of Amgen’s Enbrel pacbiztimes.com
PFDA approves biosimilar of Amgen’s Neulasta pacbiztimes.com
PBiosimilar competition hurts Amgen’s top line pacbiztimes.com
AbbVie’s Response Regarding Amgen’s Third-Party Patent Dance Discovery Request jdsupra.com
PAmgen launches Humira biosimilar in Europe pacbiztimes.com
Europe